Applications Published 12 December 2001
            
    
                Published: 1-Sep-2002
    
    
            
            
                           
        
    
    The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
                         
                    
                    The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Method for making pharmaceutical tablets by compression
Talc de Luzenac	1161218*
Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use
Merck	1161221*
Method of treating hair loss using non-immunosuppressive compounds
University of Texas Southwestern Medical Centre	1161222*
Metered dose inhalers with isobutane as propellant
IG Spruehtechnik	1161225*
Phospholine linked prodrug derivatives
SuperGen	1161226*
Microparticles for the delivery of nucleic acid
Zycos	1161227*
Compsn comprising isoquercetin and ascorbic acid in a sustained release form
Merck	1161228*
Method for preventing crystal growth and particulate aggregation in nanoparticulate compsns
Elan Pharma	1161229*
Transdermal therapy system and method for producing the same LTS Lohmann 
Therapie-Systeme	1161230*
Method of inhibiting a chaperone protein
The United States of America, as represented by the Secretary, Dept of Health and Human Services	1161231*
Hydroxy diphenyl urea sulphonamides as IL-8 receptor antagonists
SmithKline Beecham	1161232*
LXR modulators
Tularik	1161233*
Method for delivering benzidine prostaglandins by inhalation
United Therapeutics Corp	1161234*
Combinations for the treatment of diseases involving angiogenesis
Angiogene Pharmaceuticals	1161235*
Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
Merck	1161236*
Protease inhibitors
SmithKline Beecham	1161237*
Amyotropic lateral sclerosis treatment with a combination of riluzole and an AMPA receptor antagonist
Aventis Pharma	1161238*
3-cyclopropylemthoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benxamide in the treatment of multiple sclerosis Byk Gulden Lomberg Chemische 
Fabrik	1161239*
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
Du Pont Pharmaceuticals	1161240*
Stable pharmaceutical application form for paroxetin anhydrate
RP Scherer; Knoll	1161241*
Compsn and method for treating diabetes
Beyer, Camille	1161242*
Pharmaceutical compsns comprising a pyrimidine derivative and cyclodextrin
Knoll	1161243*
Use of 1,2,4-triazolo(1m5-A)pyrimidine derivatives for treating migraine
Knoll	1161244*
Method and compsn for prevention of scar formation in glaucoma filtration bleb and drainage fistula
Synphora	1161245*
Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogues thereof
Inspire Pharmaceuticals	1161246*
Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolised antibiotic
Pathogenesis Corp	1161247*
Pharmaceutical compsn containing nitrate source and an acidifying agent for treating skin ischaemia Queen Mary and Westfield 
College	1161248*
Immunostimulant bacterial membrane fractions in cancer treatment
Pierre Fabre Medicament	1161250*
Use of a compsn containing Klebsiella pneumoniae proteoglycans, and bacterial ribosomes or ribosomal RNAs for treating and/or preventing periodontal diseases
Pierre Fabre Sante	1161251*
Use of extracts from Gingko bilboa for treating sleep disorders
Medichemie	1161252*
Use of hop flowers for medicinal treatments
van Eijsselstein, Danny; van Eeuwijk, Wouter	1162253*
Treatment of autoimmune diseases with American ginseng extract
CV Technologies	1161254*
Methods and compsns for treating erectile dysfunction
Merck	1161255*
Use of nerve growth factor for therapy of intraocular tissue pathologies
Anabasis	1161256*
Pharmaceutical compsns containing TGF-beta
Novartis	1161257*
Compsns and methods for use of LDL-like receptor ligands for the treatment of cancer and angiogenic-based disease
EntreMed	1161258*
Intranasal delivery of Pneumococcal polysaccharide vaccines
Aventis Pasteur	1161259*
Tumour necrosis factor antagonists for the treatment of neurological disorders
Tobinick, Edward; Tobinik, Arthur Jerome	1161260*
Apoptosis inducing molecule and methods of use
Human Genome Sciences; Ebner, Richard; Yu, Guo-Liang; Zhai, Yifan; Ullrich, Stephen	1161261*
Analgesic compsns comprising anti-epileptic compounds and methods of using same
Warner-Lambert	1161263*
Polymer compsns for polynucleotide delivery
West Pharmaceutical Services Drug Delivery & Clinical Research Centre	1161264*